Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

North America Protein Expression Market Outlook

The North America protein expression market size was valued at USD 0.9 billion in 2023, driven by the increasing emphasis on developing effective therapeutics for treating chronic diseases in the region. The market is expected to grow at a CAGR of 8.23% during the forecast period of 2024-2032, with the values likely to rise from USD 1 billion in 2024 to USD 1.9 billion by 2032.

Key Takeaways

  • 6 out of 10 Americans are affected by at least one chronic disease, according to the Centers for Disease Control and Prevention (CDC), which fuels the demand for protein-based therapeutics.
  • Several key players are entering into strategic partnerships to create efficient protein expression systems. In July 2023, Ginkgo Bioworks announced the completion of the pilot phase of their partnership with Novo Nordisk A/S to develop novel expression systems for pharmaceutical products.
  • Advancements in protein expression technologies are attracting major investments from various sectors. In July 2023, Toronto based Liberum Biotech Inc ., secured USD 1.8 million in seed funding for its platform called “protein synthesis as a service”.

North America Protein Expression Market Analysis

Protein expression involves the synthesis, modification, and regulation of proteins in living organisms. The study of protein expression can help to determine the best treatment as well as its effectiveness in a patient. For instance, understanding protein expression in cancer cells can provide information about the cancer subtype, the optimal treatment plan, and its efficacy. The rising interest in personalized medicine is likely to propel the North America protein expression market growth in the coming years.

The market is witnessing increased demand for protein-based therapeutics, which can be attributed to the rise in the burden of chronic diseases in North America. According to the Centers for Disease Control and Prevention (CDC), 6 out of 10 Americans are affected by at least one chronic disease. These chronic diseases, including cancer, diabetes, and heart disease, are the leading drivers of death and disability in the region and are also responsible for substantial healthcare expenditure. The rising prevalence of chronic diseases is expected to directly augment the market demand as proteins are utilized in both the study as well as the treatment of such conditions.

The North America protein expression market demand is driven by the growing pipeline of biological medicines such as monoclonal antibodies, gene therapies, and vaccines. This expansion in the biologics market fuels the need for robust protein expression systems that are both flexible and efficient. To manufacture such complex expression systems, several key players are entering into partnerships to share resources and expertise. In July 2023, Ginkgo Bioworks (a United States-based biotechnology company) announced the completion of the pilot phase of their partnership with Novo Nordisk A/S to develop novel expression systems for pharmaceutical products. Through collaborative efforts, the companies achieved their first milestone which included extensive modification and testing of a microbial expression system. The development of such engineered biological systems that can offer potential treatment options for patients with serious chronic diseases is anticipated to accelerate market growth.

One of the significant North America protein expression market trends is the increased advancements in protein expression technologies that allow scalable and cost-effective protein production and attract major investments from various sectors. In July 2023, Liberum Biotech Inc ., a Toronto-based startup, secured USD 1.8 million in seed funding for its platform “protein synthesis as a service” to support the development of its synthetic protein production technology. The company plans to use the funds to increase its production capacity and expand its portfolio of available proteins which also include the production of therapeutics and enzymes. The launch of innovative cell-free and cell-based platforms for protein synthesis is expected to bolster the market share in the forecast period.

North America Protein Expression Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup Categories
Product Expression Vectors, Competent Cells, Reagents, Instruments, Services
Application Industrial, Research, Therapeutic, Others
System Type Mammalian Cell Expression System, Yeast Cell Expression System, Insect Cell Expression System
End User Academic Research, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others
Country United States, Canada

North America Protein Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Thermo Fisher Scientific Inc.
  • GenScript Biotech Corporation
  • Agilent Technologies Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • Promega Corporation
  • New England Biolabs
  • Becton, Dickinson and Company
  • Merck KGaA

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Application
  • System Type
  • End User
  • Region
Breakup by Product
  • Expression Vectors
  • Competent Cells
  • Reagents
  • Instruments
  • Services
Breakup by Application
  • Industrial
  • Research
  • Therapeutic
  • Others
Breakup by System Type
  • Mammalian Cell Expression System
  • Yeast Cell Expression System
  • Insect Cell Expression System 
Breakup by End User
  • Academic Research
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Others
Breakup by Region
  • United States
  • Canada
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Thermo Fisher Scientific Inc.
  • GenScript Biotech Corporation
  • Agilent Technologies Inc. 
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • Promega Corporation
  • New England Biolabs
  • Becton, Dickinson and Company
  • Merck KGaA 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 0.9 billion in 2023 driven by the advancements in protein expression technologies in the region.

The market is anticipated to grow at a CAGR of 8.23% during the forecast period of 2024-2032, likely to reach a market value of USD 1.9 billion by 2032. 

The growing prevalence of chronic diseases and the rising healthcare expenditure are fuelling the demand for the market.

One of the significant trends in the market is the increased strategic collaborations amongst the prominent market players. In July 2023, Ginkgo Bioworks (a United States-based biotechnology company) announced the completion of the pilot phase of their partnership with Novo Nordisk A/S to develop novel expression systems for pharmaceutical products.

Based on the product, the market is segmented into expression vectors, competent cells, reagents, instruments, and services.

Major applications of the market are industrial, research, and therapeutics among others.

By system type, the market is divided into mammalian cell expression system, yeast cell expression system, insect cell expression system.

End users of the market are academic research, contract research organizations, and pharmaceutical and biotechnology companies among others.

The market segmentation by countries includes the United States of America and Canada.

The key players in the market are Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Agilent Technologies Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Promega Corporation, New England Biolabs, Becton, Dickinson and Company, and Merck KGaA.

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,299

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 4,899

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 5,899

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124